-
Je něco špatně v tomto záznamu ?
Encapsulation of Amikacin into Microparticles Based on Low-Molecular-Weight Poly(lactic acid) and Poly(lactic acid-co-polyethylene glycol)
M. Glinka, K. Filatova, J. Kucińska-Lipka, ED. Bergerova, A. Wasik, V. Sedlařík
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- amikacin aplikace a dávkování chemie MeSH
- antibakteriální látky aplikace a dávkování chemie MeSH
- Escherichia coli účinky léků MeSH
- Klebsiella pneumoniae účinky léků MeSH
- laktáty chemie MeSH
- mikrobiální testy citlivosti MeSH
- molekulová hmotnost MeSH
- nosiče léků chemie MeSH
- polyestery chemie MeSH
- polyethylenglykoly chemie MeSH
- polyvinylalkohol chemie MeSH
- příprava léků metody MeSH
- Pseudomonas aeruginosa účinky léků MeSH
- rozpustnost MeSH
- Staphylococcus aureus účinky léků MeSH
- tobolky MeSH
- uvolňování léčiv MeSH
- velikost částic MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
The aim of this study was to fabricate novel microparticles (MPs) for efficient and long-term delivery of amikacin (AMI). The emulsification method proposed for encapsulating AMI employed low-molecular-weight poly(lactic acid) (PLA) and poly(lactic acid-co-polyethylene glycol) (PLA-PEG), both supplemented with poly(vinyl alcohol) (PVA). The diameters of the particles obtained were determined as less than 30 μm. Based on an in-vitro release study, it was proven that the MPs (both PLA/PVA- and PLA-PEG/PVA-based) demonstrated long-term AMI release (2 months), the kinetics of which adhered to the Korsmeyer-Peppas model. The loading efficiencies of AMI in the study were determined at the followings levels: 36.5 ± 1.5 μg/mg for the PLA-based MPs and 106 ± 32 μg/mg for the PLA-PEG-based MPs. These values were relatively high and draw parallels with studies published on the encapsulation of aminoglycosides. The MPs provided antimicrobial action against the Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, and Klebsiella pneumoniae bacterial strains. The materials were also comprehensively characterized by the following methods: differential scanning calorimetry; gel permeation chromatography; scanning electron microscopy; Fourier transform infrared spectroscopy-attenuated total reflectance; energy-dispersive X-ray fluorescence; and Brunauer-Emmett-Teller surface area analysis. The findings of this study contribute toward discerning new means for conducting targeted therapy with polar, broad spectrum antibiotics.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22012305
- 003
- CZ-PrNML
- 005
- 20220506130424.0
- 007
- ta
- 008
- 220425s2021 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1021/acs.molpharmaceut.1c00193 $2 doi
- 035 __
- $a (PubMed)34196555
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Glinka, Marta $u Department of Analytical Chemistry, Faculty of Chemistry, Gdańsk University of Technology, G. Narutowicza 11/12, Gdańsk 80-233, Poland $1 https://orcid.org/0000000343920344
- 245 10
- $a Encapsulation of Amikacin into Microparticles Based on Low-Molecular-Weight Poly(lactic acid) and Poly(lactic acid-co-polyethylene glycol) / $c M. Glinka, K. Filatova, J. Kucińska-Lipka, ED. Bergerova, A. Wasik, V. Sedlařík
- 520 9_
- $a The aim of this study was to fabricate novel microparticles (MPs) for efficient and long-term delivery of amikacin (AMI). The emulsification method proposed for encapsulating AMI employed low-molecular-weight poly(lactic acid) (PLA) and poly(lactic acid-co-polyethylene glycol) (PLA-PEG), both supplemented with poly(vinyl alcohol) (PVA). The diameters of the particles obtained were determined as less than 30 μm. Based on an in-vitro release study, it was proven that the MPs (both PLA/PVA- and PLA-PEG/PVA-based) demonstrated long-term AMI release (2 months), the kinetics of which adhered to the Korsmeyer-Peppas model. The loading efficiencies of AMI in the study were determined at the followings levels: 36.5 ± 1.5 μg/mg for the PLA-based MPs and 106 ± 32 μg/mg for the PLA-PEG-based MPs. These values were relatively high and draw parallels with studies published on the encapsulation of aminoglycosides. The MPs provided antimicrobial action against the Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, and Klebsiella pneumoniae bacterial strains. The materials were also comprehensively characterized by the following methods: differential scanning calorimetry; gel permeation chromatography; scanning electron microscopy; Fourier transform infrared spectroscopy-attenuated total reflectance; energy-dispersive X-ray fluorescence; and Brunauer-Emmett-Teller surface area analysis. The findings of this study contribute toward discerning new means for conducting targeted therapy with polar, broad spectrum antibiotics.
- 650 _2
- $a amikacin $x aplikace a dávkování $x chemie $7 D000583
- 650 _2
- $a antibakteriální látky $x aplikace a dávkování $x chemie $7 D000900
- 650 _2
- $a tobolky $7 D002214
- 650 _2
- $a nosiče léků $x chemie $7 D004337
- 650 _2
- $a příprava léků $x metody $7 D004339
- 650 _2
- $a uvolňování léčiv $7 D065546
- 650 _2
- $a Escherichia coli $x účinky léků $7 D004926
- 650 _2
- $a Klebsiella pneumoniae $x účinky léků $7 D007711
- 650 _2
- $a laktáty $x chemie $7 D007773
- 650 _2
- $a mikrobiální testy citlivosti $7 D008826
- 650 _2
- $a molekulová hmotnost $7 D008970
- 650 _2
- $a velikost částic $7 D010316
- 650 _2
- $a polyestery $x chemie $7 D011091
- 650 _2
- $a polyethylenglykoly $x chemie $7 D011092
- 650 _2
- $a polyvinylalkohol $x chemie $7 D011142
- 650 _2
- $a Pseudomonas aeruginosa $x účinky léků $7 D011550
- 650 _2
- $a rozpustnost $7 D012995
- 650 _2
- $a Staphylococcus aureus $x účinky léků $7 D013211
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Filatova, Katerina $u Centre of Polymer Systems, University Institute, Tomas Bata University in Zlín, Tomáše Bati 5678, Zlín 76001, Czech Republic
- 700 1_
- $a Kucińska-Lipka, Justyna $u Department of Polymers Technology, Faculty of Chemistry, Gdańsk University of Technology, G. Narutowicza 11/12, Gdańsk 80-233, Poland $1 https://orcid.org/0000000185223198
- 700 1_
- $a Bergerova, Eva Domincova $u Centre of Polymer Systems, University Institute, Tomas Bata University in Zlín, Tomáše Bati 5678, Zlín 76001, Czech Republic
- 700 1_
- $a Wasik, Andrzej $u Department of Analytical Chemistry, Faculty of Chemistry, Gdańsk University of Technology, G. Narutowicza 11/12, Gdańsk 80-233, Poland $1 https://orcid.org/0000000217583893
- 700 1_
- $a Sedlařík, Vladimir $u Centre of Polymer Systems, University Institute, Tomas Bata University in Zlín, Tomáše Bati 5678, Zlín 76001, Czech Republic
- 773 0_
- $w MED00008279 $t Molecular pharmaceutics $x 1543-8392 $g Roč. 18, č. 8 (2021), s. 2986-2996
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34196555 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220425 $b ABA008
- 991 __
- $a 20220506130417 $b ABA008
- 999 __
- $a ok $b bmc $g 1789755 $s 1163506
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 18 $c 8 $d 2986-2996 $e 20210701 $i 1543-8392 $m Molecular pharmaceutics $n Mol Pharm $x MED00008279
- LZP __
- $a Pubmed-20220425